Research study Program year 2021 Source: CMS Open Payments

Akb-6548-Ci-0016

ClinicalTrials.gov NCT02865850

Research payments

$398,025

304 payments

Through program year 2021, $398,025 in research payments was reported against Akb-6548-Ci-0016, across 304 payments, paid by Akebia Therapeutics Inc.

Paid by: Akebia Therapeutics Inc
ClinicalTrials.gov: NCT02865850

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$398,025	304

Breakdown

Who paid Research payments · program year 2021

Akebia Therapeutics Inc $398,025 304 payments

Who received the money Research payments · program year 2021

Total Renal Research INC Organisation paid for research $154,118 79 payments
Frenova LLC Organisation paid for research $148,610 207 payments
Socal Research Associates Organisation paid for research $46,212 9 payments
Elias Research Associates LLC Organisation paid for research $27,187 1 payment
NewPhase Clinical Trials Corp Organisation paid for research $9,920 1 payment
Renal Consultants Medical Group Organisation paid for research $8,760 2 payments
Western Nephrology And Metabolic Bone Organisation paid for research $2,266 2 payments
Arlington Nephrology Organisation paid for research $952 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.